Stock RCM R1 RCM INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials R1 RCM Inc. Nasdaq

Equities

RCM

US7493971052

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
11.9 USD +0.68% Intraday chart for R1 RCM Inc. -0.75% -49.62%
Apr. 18 R1 RCM's Q1 Results to Focus on Strategic Alternatives, Change Cyberattack, RBC Says MT
Apr. 11 North American Morning Briefing : Stock Futures -2- DJ

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,465 2,802 7,046 4,561 4,432 5,007 - -
Enterprise Value (EV) 1 1,727 3,180 7,689 6,237 5,896 6,844 6,624 6,287
P/E ratio -162 x 72.8 x 69.8 x -68.4 x 1,057 x -171 x 53.8 x 32.4 x
Yield - - - - - - - -
Capitalization / Revenue 1.24 x 2.21 x 4.78 x 2.52 x 1.97 x 1.89 x 1.7 x 1.55 x
EV / Revenue 1.46 x 2.5 x 5.21 x 3.45 x 2.62 x 2.59 x 2.25 x 1.94 x
EV / EBITDA 10.3 x 13.3 x 22.4 x 14.7 x 9.6 x 10.4 x 8.52 x 7.09 x
EV / FCF 32.6 x 254 x 36.1 x -60.3 x 24.8 x 44.4 x 22.2 x 14.8 x
FCF Yield 3.06% 0.39% 2.77% -1.66% 4.03% 2.25% 4.5% 6.74%
Price to Book 81.8 x - 20.5 x 1.2 x 1.74 x 1.91 x 1.82 x 1.69 x
Nbr of stocks (in thousands) 112,865 116,662 276,434 416,511 419,308 420,730 - -
Reference price 2 12.98 24.02 25.49 10.95 10.57 11.90 11.90 11.90
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,186 1,271 1,475 1,806 2,254 2,644 2,947 3,235
EBITDA 1 168 240 343.6 425.5 614.3 658 777.2 886.9
EBIT 1 57.7 80 145.7 3 147.9 111.9 246.8 348.9
Operating Margin 4.86% 6.3% 9.88% 0.17% 6.56% 4.23% 8.37% 10.79%
Earnings before Tax (EBT) 1 9.8 118.4 126.8 -61 21 -12.4 235.7 222.7
Net income 1 -8.7 117.1 97.2 -57.6 3.3 -0.749 127.2 170.6
Net margin -0.73% 9.21% 6.59% -3.19% 0.15% -0.03% 4.31% 5.27%
EPS 2 -0.0800 0.3300 0.3652 -0.1600 0.0100 -0.0696 0.2213 0.3674
Free Cash Flow 1 52.9 12.5 213.1 -103.4 237.6 154.3 298 423.8
FCF margin 4.46% 0.98% 14.45% -5.72% 10.54% 5.84% 10.11% 13.1%
FCF Conversion (EBITDA) 31.49% 5.21% 62.02% - 38.68% 23.45% 38.34% 47.79%
FCF Conversion (Net income) - 10.67% 219.24% - 7,200% - 234.32% 248.4%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 379.7 398.9 385.7 391.9 496 532.8 545.6 560.7 572.8 575.1 609.2 635.7 687 711.4 690
EBITDA 1 89.3 95.1 89.3 87.2 124 125 142.2 142.9 161.5 167.7 147.6 146.5 177.5 187.5 176.5
EBIT 1 31.1 50.2 43.2 -38 2 -4.2 33.7 23.9 41.2 49.1 16.67 22.67 27.87 46.87 47
Operating Margin 8.19% 12.58% 11.2% -9.7% 0.4% -0.79% 6.18% 4.26% 7.19% 8.54% 2.74% 3.57% 4.06% 6.59% 6.81%
Earnings before Tax (EBT) 1 24.6 45.1 38.5 -44.9 -21.7 -32.9 3 -8.6 9.1 17.5 -13.91 -8.724 2.438 20.65 34.19
Net income 1 17 36 29.4 -20.4 -29.5 -37.1 0.3 0.3 1.3 1.4 -13.26 -9.291 4.424 17.36 42.35
Net margin 4.48% 9.02% 7.62% -5.21% -5.95% -6.96% 0.05% 0.05% 0.23% 0.24% -2.18% -1.46% 0.64% 2.44% 6.14%
EPS 2 0.0500 0.1100 0.0900 -0.0700 -0.0700 -0.0900 0.000700 - - 0.003100 -0.0172 -0.0225 0.008470 0.0280 0.0286
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/2/21 2/17/22 5/9/22 8/3/22 11/8/22 2/16/23 5/4/23 8/2/23 11/2/23 2/27/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 262 378 642 1,676 1,464 1,837 1,618 1,280
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.56 x 1.576 x 1.869 x 3.94 x 2.383 x 2.792 x 2.081 x 1.443 x
Free Cash Flow 1 52.9 12.5 213 -103 238 154 298 424
ROE (net income / shareholders' equity) 98.4% 108% 44.7% -3.76% 0.12% -0.91% 2.16% 4.54%
ROA (Net income/ Total Assets) 9.84% 5.38% 7.37% -1.75% 0.07% -2.72% 0.08% 1.37%
Assets 1 -88.46 2,176 1,319 3,295 5,038 27.55 155,680 12,482
Book Value Per Share 2 0.1600 - 1.250 9.120 6.060 6.240 6.550 7.030
Cash Flow per Share 2 - - 0.9900 -0.0300 0.7500 0.5800 1.100 1.220
Capex 1 61 49.3 51.7 93.5 103 123 139 153
Capex / Sales 5.14% 3.88% 3.51% 5.18% 4.55% 4.66% 4.7% 4.73%
Announcement Date 2/20/20 2/18/21 2/17/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for R1 RCM Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
11.9 USD
Average target price
16.93 USD
Spread / Average Target
+42.26%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. RCM Stock
  4. RCM Stock
  5. Financials R1 RCM Inc.